To address the COVID-19 public health emergency fiscal burdens, Congress authorized and appropriated the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act[1], Public Health and Social ...

The official response, as provided by Sega, is that the company will make use of efficient development methods, including the use of AI in game development.

Misuse of an automated information system is sometimes illegal, often unethical, and always reflects poor judgment or lack of care in following security rules and regulations. Misuse may, ...

This applies to all users and uses of electronic resources licensed or made available by similar agreements by the Saint Louis University Libraries (licenses or similar agreements hereafter referred ...

PLYMOUTH MEETING, Pa., July 7, 2021 /PRNewswire/ — The National Comprehensive Cancer Network (R) (NCCN (R)), an alliance of 31 leading cancer centers, has again qualified as a provider-led entity (PLE ...

Seventeen clinical scenarios developed for which amyloid or tau PET may be considered. HealthDay News — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) ...

The American College of Cardiology, along with several partnering organizations, today released updated appropriate use criteria for performing coronary revascularization in patients with acute ...

The ACC, AHA, and other organizations have released updated appropriate use criterial for coronary revascularization. The 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update ...

The American College of Cardiology's National Cardiovascular Data Registry was the source of data for research published throughout 2016, including a study examining if atrial fibrillation patients ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today ...

The Food and Drug Administration’s approval of Biogen and Eisai’s anti-amyloid antibody aducanumab on June 7 left many questions unanswered, including how to use the drug in clinical practice. Since ...

Multiple sclerosis (MS) is a complex chronic, progressing disease that contributes to poor quality of life (QOL) for patients and high costs for managed care organizations. Currently, ...